News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,714 Results
Type
Article (41160)
Company Profile (267)
Press Release (681277)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204896)
Career Advice (2022)
Deals (35572)
Drug Delivery (110)
Drug Development (81524)
Employer Resources (173)
FDA (16471)
Job Trends (14958)
News (346889)
Policy (32783)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2577)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49633)
ALS (167)
Alzheimer's disease (1661)
Antibody-drug conjugate (ADC) (305)
Approvals (16735)
Artificial intelligence (500)
Autoimmune disease (143)
Automation (37)
Bankruptcy (361)
Best Places to Work (11647)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (631)
Cancer (4753)
Cardiovascular disease (400)
Career advice (1707)
Career pathing (35)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (728)
Cervical cancer (36)
Clinical research (69607)
Collaboration (1669)
Company closure (4)
Compensation (1146)
Complete response letters (52)
COVID-19 (2708)
CRISPR (87)
C-suite (810)
Cystic fibrosis (143)
Data (6153)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (496)
Diagnostics (6674)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (241)
Drug pricing (185)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90125)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117383)
Executive appointments (958)
FDA (19551)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1445)
Gene editing (191)
Generative AI (42)
Gene therapy (582)
GLP-1 (962)
Government (4662)
Grass and pollen (6)
Guidances (383)
Healthcare (18902)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (245)
Immuno-oncology (54)
Indications (103)
Infectious disease (2967)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (243)
Interviews (315)
IPO (16654)
IRA (49)
Job creations (3648)
Job search strategy (1427)
JPM (56)
Kidney cancer (16)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7965)
Liver cancer (91)
Longevity (14)
Lung cancer (638)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (776)
MASH (162)
Medical device (13810)
Medtech (13862)
Mergers & acquisitions (19975)
Metabolic disorders (1252)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2867)
Neurotech (1)
NextGen: Class of 2026 (6522)
Non-profit (4516)
Now hiring (65)
Obesity (586)
Opinion (257)
Ovarian cancer (164)
Pain (196)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (34)
Patents (487)
Patient recruitment (471)
Peanut (55)
People (58887)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21708)
Phase 2 (30633)
Phase 3 (22815)
Pipeline (5078)
Policy (278)
Postmarket research (2573)
Preclinical (9220)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (813)
Real estate (5957)
Recruiting (69)
Regulatory (24449)
Reports (51)
Research institute (2389)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (184)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3621)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (983)
Venture capital (86)
Weight loss (376)
Women's health (87)
Worklife (18)
Date
Last 7 days (592)
Last 30 days (1943)
Last 365 days (29772)
2026 (2814)
2025 (30221)
2024 (35248)
2023 (40121)
2022 (51218)
2021 (55744)
2020 (54132)
2019 (46618)
2018 (35062)
2017 (32178)
2016 (31566)
2015 (37631)
2014 (31423)
2013 (26467)
2012 (28695)
2011 (29372)
2010 (27459)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39347)
Australia (6430)
California (11174)
Canada (3252)
China (1083)
Colorado (471)
Connecticut (470)
Delaware (332)
Europe (84723)
Florida (1663)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (851)
India (62)
Indiana (513)
Iowa (22)
Japan (418)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1370)
Massachusetts (7994)
Michigan (319)
Minnesota (622)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2965)
New Mexico (28)
New York (2943)
North Carolina (1433)
North Dakota (8)
Northern California (5453)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2252)
Puerto Rico (22)
Rhode Island (47)
South America (1108)
South Carolina (65)
South Dakota (1)
Southern California (4339)
Tennessee (172)
Texas (1720)
United States (39576)
Utah (334)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (915)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
722,714 Results for "lemaitre vascular inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LeMaitre Q3 2025 Financial Results
November 6, 2025
·
14 min read
Press Releases
LeMaitre to Participate in Upcoming Investor Conferences - November 12, 2025
November 13, 2025
·
1 min read
Press Releases
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
October 9, 2025
·
1 min read
Press Releases
LeMaitre to Participate at Upcoming Investor Conferences in September 2025
August 29, 2025
·
1 min read
Press Releases
LeMaitre Vascular Prices $150 Million Convertible Senior Notes
December 18, 2024
·
6 min read
Genetown
LeMaitre to Present at the 2024 Jefferies Global Healthcare Conference
LeMaitre Vascular, Inc. announced that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00 AM ET at the Marriott Marquis in New York City.
May 21, 2024
·
1 min read
Genetown
LeMaitre to Participate at Upcoming Investor Conferences in March 2024
LeMaitre Vascular, Inc. announced that management will be participating in four upcoming investor conferences in March.
March 1, 2024
·
1 min read
Press Releases
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025
July 8, 2025
·
1 min read
Business
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close.
April 19, 2024
·
1 min read
Press Releases
Aquedeon Medical Inc. Receives FDA Approval to Expand Clinical Trial of Duett Vascular Graft System
August 13, 2025
·
2 min read
1 of 72,272
Next
